Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.47 |
| ▸ | ELANE | P08246 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.40 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.40 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.40 |
| ▸ | NSD2 | O96028 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6554232 | 0.84 | ATM (0.52) | ATML3MBTL1SLC1A3ELANETDP1 | |
| SCHEMBL6305898 | 0.84 | ATM (0.52) | ATML3MBTL1SLC1A3ELANETDP1 | |
| SCHEMBL27432565 | 0.83 | ATM (0.50) | ATML3MBTL1SLC1A3ELANETDP1 | |
| SCHEMBL27750014 | 0.83 | ATM (0.50) | ATML3MBTL1SLC1A3ELANETDP1 | |
| SCHEMBL27750013 | 0.83 | ATM (0.50) | ATML3MBTL1SLC1A3ELANETDP1 | |
| SCHEMBL285949 | 0.81 | ELANE (0.53) | ATML3MBTL1SLC1A3ELANETDP1 | |
| SCHEMBL133568 | 0.81 | ELANE (0.53) | ATML3MBTL1SLC1A3ELANETDP1 | |
| SCHEMBL9939655 | 0.81 | ELANE (0.53) | ATML3MBTL1SLC1A3ELANETDP1 | |
| SCHEMBL9485663 | 0.81 | ELANE (0.53) | ATML3MBTL1ELANETDP1HPGD | |
| SCHEMBL28990068 | 0.81 | ATM (0.49) | ATML3MBTL1SLC1A3ELANETDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007094006-A1 | PROCESS FOR PREPARATION OF CLOPIDOGREL BISULFATE FORM 1 | LEE PHARMA LIMITED (IN) | 2007-08-23 | — | — | WO | claimed |
| US-20070191609-A1 | PROCESS FOR PREPARATION OF CLOPIDOGREL BISULPHATE FORM-1 | LEE PHARMA LIMITED (IN) | 2007-08-16 | — | — | US | claimed |
| WO-2007094006-A1 | PROCESS FOR PREPARATION OF CLOPIDOGREL BISULFATE FORM 1 | LEE PHARMA LIMITED (IN) | 2007-08-23 | — | — | WO | disclosed |
| US-20070191609-A1 | PROCESS FOR PREPARATION OF CLOPIDOGREL BISULPHATE FORM-1 | LEE PHARMA LIMITED (IN) | 2007-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070191609-A1 | PROCESS FOR PREPARATION OF CLOPIDOGREL BISULPHATE FORM-1 | SULT1A1, SF1, ADH1C | ATM 1562/4885L3MBTL1 4648/4885SLC1A3 3967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.